Get startedLog in
    Picture of HUTCHMED (China) logo

    13 — HUTCHMED (China) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination

    Picture of HUTCHMED (China) logoHUTCHMED (China)
    29/09/2026 01:16
    AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination
    Sept 29 (Reuters) - HUTCHMED (China) 0013.HK said on Tuesday Anglo-Swedish drugmaker AstraZeneca AZN.L had filed an application with the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination in patients with advanced lung cancer.
    ORPATHYS is being jointly developed by AstraZeneca and HUTCHMED and is commercialised by AstraZeneca.

     (Reporting by Roshan Thomas in Bengaluru; Editing by Subhranshu Sahu)
     ((Roshan.Thomas@thomsonreuters.com;))

    Recent news on HUTCHMED (China)

    See all news